Searchable abstracts of presentations at key conferences in endocrinology

ea0090p417 | Pituitary and Neuroendocrinology | ECE2023

A negative association between growth hormone secretion and inflammation in adult patients with non-functioning pituitary mass

Seki Yasufumi , Bokuda Kanako , Morimoto Satoshi , Watanabe Satoshi , Yamashita Kaoru , Takano Noriyoshi , Watanabe Daisuke , Ichihara Atsuhiro

Background: Growth hormone (GH) deficiency, which causes visceral obesity and non-alcohol fatty liver disease, increases cardiovascular event risks. High-sensitivity C-reactive protein (hs-CRP), an inflammatory marker associated with increased cardiovascular risk, reportedly decreased after GH supplementation in GH-deficient patients, however, the association between GH secretion and inflammation remains unclear.Patients and Methods: We retrospectively i...

ea0041ep1008 | Thyroid (non-cancer) | ECE2016

Soluble (Pro)rennin receptor levels in patients with graves disease

Mizuguchi Yuki , Yatabe Midori , Yatabe Junichi , Seki Yasufumi , Niyama Michita , Bokuda Kanako , Watabnabw Daisuke , Ando Takashi , Morimoto Satoshi , Ichihara Atsuhiro

Background: (Pro)renin receptor[(P)RR] is a multi-functioning transmembrane protein which plays key roles in the regulation of tissue renin-angiotensin system (RAS). (P)RR is cleaved by furin to generate soluble (P)RR[s(P)RR], which is secreted into extracellular space. We previously reported that high blood concentration of s(P)RR indicates poor organ prognosis in several diseases. In this way, s(P)RR is expected as a candidate biomarker for reflecting the tissue RAS status, ...

ea0081p158 | Pituitary and Neuroendocrinology | ECE2022

Effect of growth hormone deficiency on serum high-sensitivity C-reactive protein levels in adult patients with non-functioning pituitary tumors

Seki Yasufumi , Takano Noriyoshi , Yamashita Kaoru , Bokuda Kanako , Sasaki Nobukazu , Ishikawa Toru , Kimura Miwa , Watanabe Satoshi , Watanabe Daisuke , Morimoto Satoshi , Ichihara Atsuhiro

Background: Growth hormone (GH) deficiency causes visceral obesity and fatty liver and increases cardiovascular event risks. Because serum high-sensitivity C-reactive protein (hs-CRP) levels, which has been used to estimate those risks, was reported to be decreased by GH supplementation therapy in GH deficient patients, it has been suggested that inflammatory processes might be activated in GH deficient state. However, the clinical factors associated with increased hs-CRP leve...

ea0037ep1206 | Clinical Cases–Pituitary/Adrenal | ECE2015

Effectiveness of octoreotide administration before surgery for GH-TSH co-secreting pituitary adenoma with thyrotoxicosis: a case report

Kimura Shihori , Isozaki Osamu , Fukuda Izumi , Morimoto Satoshi , Seki Yasufumi , Yamashita Kaoru , Takano Noriyoshi , Otsuki Akiko , Kaneshige Terumi , Bokuda Kanako , Watanabe Daisuke , Ando Takashi , Hizuka Naomi , Amano Kosaku , Komori Takashi , Okada Yoshikazu , Ichihara Atsuhiro

Introduction: TSH-secreting pituitary adenoma (TSHoma) sometimes brings on rare cause of hyperthyroidism because of its excessive TSH secretion. Though the first line of treatment for TSHoma is surgical removal of tumour, hyperthyroidism often causes perioperative thyroid storm. Here, we report a case of GH-TSH pituitary adenoma whose thyrotoxicosis was controlled by 5 daysÂ’ octoreotide (OCT) subcutaneous administration before surgery.Case report: A...